Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2022 | Story Leonie Bolleurs | Photo Supplied
WJ swart
Prof Wijnand Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

Plant health is important for the survival of our planet and all its living creatures. Now, imagine an instrument that contains a DNA chip from virtually every known plant pathogen, where one can simply snip off a piece of the infected plant material, slip it into the ‘plant disease tricorder’, and within seconds you have not only a diagnosis of the disease, but all the information about its control too.

According to Prof Wijnand Swart, Professor of Plant Pathology in the Department of Plant Sciences at the University of the Free State (UFS) and President of the Southern African Society for Plant Pathology (SASPP), this concept might be a bit far-fetched, but is a distinct possibility for the not-too-distant future. “Without a doubt …,” he believes.

He was recently a guest on a series of radio talks on plant health in South Africa, hosted by the National Science and Technology Forum (NSTF) in partnership with Plaas/Farm TV (YouTube broadcaster). His talk on the topic, Whither (or wither) Plant Pathology in the next 50 years, was specifically focused on understanding the latest research and dynamics of the discipline in a South African context.

In terms of this futuristic perspective, he says collaboration between plant pathologists and biomedical and aeronautical engineers, nanotechnologists, and computer scientists will aid the development of micro-sensory technologies for the detection of new plant diseases that are relevant to biosecurity, plant disease diagnostics, and epidemiological modelling.

In his discussion, Prof Swart referred to the work of Prof John Lucas, former Head of Plant Pathology and Microbiology at the Rothamsted Research Station in the United Kingdom, who believes that there are three key issues facing plant pathologists in the 21st century. These are the strengthening of food security while simultaneously safeguarding the health of associated ecosystems and reducing the dependency on natural resources; the creation of pest and disease control systems that are sustainable and not compromised by the evolution of pest and pathogen strains; and the development of suitable crop protection technologies.

Future technologies

Based on the work of Prof Lucas, Prof Swart states that future technologies in plant health will develop in five areas. In the first area, he says DNA-based technologies will greatly increase the speed, sensitivity, and accuracy of pest and pathogen detection and diagnosis.

Also key here, is the integration of nanomaterials into disease management strategies and diagnostics. He says in the past decade, the use of nanotechnology in phytopathology has grown exponentially. According to him, nanotechnology can increase productivity using nano-pesticides and nano-fertilisers, improve soil quality by means of nano-zeolites and hydrogels, stimulate plant growth using nanomaterials, and provide smart monitoring via nano-sensors and wireless communication devices.

Prof Swart says according to Prof Lucas, the second area in which plant health technologies will grow is plant defence and immunity. When induced, plant resistance primes plants to deal with a diversity of biotic and abiotic stresses. Prospects of inducing chemically modulated plant resistance via biological agents (such as engineered microbes), might result in low-cost seed treatments, thereby removing the need for expensive chemical spray regimes.

Technology development in plant health will also become more evident in genetic diversification. Prof Swart believes sequencing the genomes of major crop species and their wild relatives will expand the known gene pool and diversify genetic resources available to plant breeders.

According to him, a new era is beckoning, where the prospect of crop pharmacology based on signal molecules and their receptors will become a reality. It will be based on the development of novel chemistries designed to manipulate specific molecular targets, by either regulating host resistance or disabling the disease-causing processes of pathogens.

The fifth area in which plant health technologies will develop, is ecological approaches to disease control. He says by understanding the ecology of pathogens, our ability to exploit their natural enemies will improve. Ecological approaches to plant disease control will have a significant impact on the introduction of invasive pathogen species, while the effect of climate change will influence the emergence of new plant diseases and epidemics. He strongly believes that it is important to take a holistic approach to understanding how and why plant pathogenesis occurs if we are to manage diseases effectively.

Future challenges

The development of these new technologies is very important, as there are several challenges that plant pathology will face in the future. These include the increasing demand for food to support the growing global population; the decreasing production potential of agriculture due to competition for fertile land; the increased risk of plant disease epidemics resulting from agricultural intensification; the depletion of natural resources; and the influence of climate change on interactions between plants and their pests or pathogens.

Prof Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

He concludes, saying that plant pathology will evolve as an interdisciplinary science. He adds that future research will focus on new problems that are traditionally seen as outside the core discipline of plant pathology. Furthermore, food security will be a dominant and important driver of plant pathology research, while the impact of climate change on plant diseases will be very significant. Finally, that the adaptive potential of plant and pathogen populations will be one of the most important predictors of the magnitude of climate change effects.

LISTEN: radio interview


News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept